The NATO Advanced Studies Institute series "Targeting of Drugs" was
originated in 1981. It is now a major international forum, held
every two years in Cape Sounion, Greece, in which the present and
the future of this important area of research in drug delivery is
discussed in great depth. Previous ASIs of the series dealt with
drug carriers of natural and synthetic origin, their interactions
with the biological milieu, ways by which milieu interference is
circumvented, approaches to carrier design or modification that
contribute to optimal carrier function, and, more recently, with
strategies for gene and oligonucleotide delivery in therapy The
present book contains the proceedings of the 9th NATO ASI,
"Targeting of Drugs: Strategies for Stealth Therapeutic Systems,"
held in Cape Sounion during 24 June -5 July 1997. As the title
implies, the book deals with a variety of approaches to evade the
reticuloendothelial system and thus extend the circulation time of
a variety of delivery systems including polymers, biopolymers,
liposomes, and other nanoparticles or microparticles. We express
our appreciation to Mrs. Concha Perring for her assistance with the
organization of the AS . The ASI was held under the sponsorship of
NATO Scientific Affairs Division and supported by Sequus
Pharmaceuticals (Menlo Park, CA, USA), The Liposome Company
(Princeton, NJ, USA), NOVO Nordisk (Bagsvaard, Denmark), NeXstar
Pharmaceuticals (Boulder, CO, USA), Gene Medicine (Houston, TX,
USA), Pfizer Ltd (Sandwich, Kent, UK), Merck (Rahway, NJ, USA), and
Biovation Ltd (Aberdeen, UK).
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!